A prospective, randomized, open-label, active-controlled study to compare the efficacy and safety of levocetirizine and bepotastine in chronic spontaneous urticaria

• Hauptverfasser: Gaurav Menghani (Verfasst von), Navneet Kaur (Verfasst von), Kapil Vyas (Verfasst von), Kalpana Gupta (Verfasst von), Kriti Maheshwari (Verfasst von), Raju Singh (Verfasst von)
• Format: Buch
• Veröffentlicht: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Management of chronic spontaneous urticaria (CSU) is challenging because of its unpredictable course and negative influence on the quality of life. Second-generation antihistaminics are the first-line treatment. Levocetirizine, a time-tested antihistaminic, has proven efficacy in CSU. Be...